Bioenergetic remodeling in the pathophysiology and treatment of nonalcoholic fatty liver disease

Eur J Clin Invest. 2022 Mar;52(3):e13749. doi: 10.1111/eci.13749.

Authors

Anabela Marisa Azul¹, Martin Winter^{2

3}, Daniel Silva¹, Liljana Georgievska¹, Paulo J Oliveira¹

Affiliations

¹ CNC-Center for Neuroscience and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, UC Biotech, Cantanhede, Portugal.
² Micro-Biolytics GmbH, Esslingen am Neckar, Germany.
³ Lab Automation Network, Tübingen, Germany.

PMID: 35156207
DOI: 10.1111/eci.13749

No abstract available

Publication types

Editorial

MeSH terms

Energy Metabolism
Humans
Non-alcoholic Fatty Liver Disease / metabolism
Non-alcoholic Fatty Liver Disease / physiopathology*
Non-alcoholic Fatty Liver Disease / therapy*

Grants and funding